Browse AMR Genes
Explore antimicrobial resistance genes from the literature
Explore antimicrobial resistance genes from the literature
outer membrane porin
Overview
| Protein Change | Nucleotide Change | Mechanism | Organism | Resistance To | Database | Validation Status |
|---|---|---|---|---|---|---|
| G120D | - | major outer membrane protein porin P.IB | Neisseria gonorrhoeae | Penicillin|TetracyclineBETA-LACTAM | Reference Gene CatalogReslit | Confirmed |
| G120K | - | decreased permeability of antimicrobials, major outer membrane protein porin P.IB | Neisseria gonorrhoeae | Penicillin|TetracyclineCeftriaxone|CefiximeCeftriaxone+2 more | Reference Gene CatalogReslit |
| Confirmed |
| G120N | - | - | Neisseria gonorrhoeae | Penicillin|TetracyclineCeftriaxone|Cefixime | Reslit | Candidate |
| A121G | - | major outer membrane protein porin P.IB | Neisseria gonorrhoeae | Penicillin|TetracyclineBETA-LACTAM | Reference Gene CatalogReslit | Confirmed |
| A121D | - | decreased permeability of antimicrobials, major outer membrane protein porin P.IB | Neisseria gonorrhoeae | Ceftriaxone|CefiximeCefiximeBETA-LACTAM | Reference Gene CatalogReslit | Confirmed |
| A121N | - | decreased permeability of antimicrobials, major outer membrane protein porin P.IB | Neisseria gonorrhoeae | Ceftriaxone|CefiximeCeftriaxoneCefixime+1 more | Reference Gene CatalogReslit | Confirmed |
| S213S | - | - | - | Ceftriaxone | Reslit | Candidate |
| S213Y | - | - | - | Ceftriaxone | Reslit | Candidate |
| T89S | - | - | - | Ceftriaxone | Reslit | Candidate |
| Q214L | - | - | - | Ceftriaxone | Reslit | Candidate |
| G259A | - | - | - | Ceftriaxone | Reslit | Candidate |
| T87A | - | - | - | Ceftriaxone | Reslit | Candidate |
| A121S | - | major outer membrane protein porin P.IB | Neisseria gonorrhoeae | PenicillinCEPHALOSPORIN/QUINOLONE/TETRACYCLINE | Reference Gene CatalogReslit | Confirmed |
| A121P | - | major outer membrane protein porin P.IB | Neisseria gonorrhoeae | BETA-LACTAM | Reference Gene Catalog | Established |
| GA120del | - | major outer membrane protein porin P.IB | Neisseria gonorrhoeae | BETA-LACTAM/TETRACYCLINE | Reference Gene Catalog | Established |
| A121H | - | major outer membrane protein porin P.IB | Neisseria gonorrhoeae | BETA-LACTAM | Reference Gene Catalog | Established |
| G120P | - | major outer membrane protein porin P.IB | Neisseria gonorrhoeae | BETA-LACTAM | Reference Gene Catalog | Established |
| G120R | - | major outer membrane protein porin P.IB | Neisseria gonorrhoeae | BETA-LACTAM | Reference Gene Catalog | Established |
| Allele | Database | Papers | Drug Classes | Organisms | Countries | Years | Sequence Accession | Protein Accession |
|---|---|---|---|---|---|---|---|---|
| porB | Reslit | 4 | Cefixime, Ceftriaxone +2 | Neisseria gonorrhoeae | Korea, Northern Territory, Australia, Russia | 2010, 2017, 2018, 2019 | FJ465093|FJ465094|FJ465095 | - |
| PorB | Reslit | 1 | Azithromycin, Tetracycline | Neisseria gonorrhoeae | Canada|United Kingdom|United States | 2020 | ERR191763|ERR191769 | - |
| porB1b_G120K | Reslit | 1 | Penicillin | Neisseria gonorrhoeae | KwaZulu-Natal, South Africa | 2021 | PRJNA681740 | - |
| porB1b_A121N | Reslit | 1 | Penicillin | Neisseria gonorrhoeae | KwaZulu-Natal, South Africa | 2021 | PRJNA681740 | - |
| porB1b | Reslit | 2 | Ceftriaxone, Cefixime | Neisseria gonorrhoeae | Kenya, New Zealand | 2021 | PRJNA660404|SAMN15960547|SAMN15960548|SAMN15960549|SAMN15960550|SAMN15960551|SAMN15960552|SAMN15960553|SAMN15960554|SAMN15960555|CP061491|CP061490|CP061498|CP061488|CP061487|CP061486|CP061492|CP061485|CP061484|CP061483 | - |
Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone.
The study identifies various penA mutations, along with mtrR, porB, and ponA mutations, associated with reduced susceptibility to cefixime and ceftriaxone in Neisseria gonorrhoeae isolates.
Molecular Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae, Northern Territory, Australia.
The study identified low levels of azithromycin resistance (0.2%) and no ceftriaxone resistance in Neisseria gonorrhoeae in the Northern Territory of Australia. It also found that ciprofloxacin resistance was significantly lower by PCR than by bacterial culture.
RNA markers enable phenotypic test of antibiotic susceptibility in Neisseria gonorrhoeae after 10 minutes of ciprofloxacin exposure.
The study identifies porB and rpmB as RNA markers that can rapidly determine antibiotic susceptibility of Neisseria gonorrhoeae to ciprofloxacin within 10 minutes of exposure.
Resistance of Neisseria gonorrhoeae isolates to beta-lactam antibiotics (benzylpenicillin and ceftriaxone) in Russia, 2015-2017.
The study identified mutations in penA, ponA, mtrR, and porB genes, as well as the presence of bla TEM plasmids, which contribute to benzylpenicillin resistance in Neisseria gonorrhoeae isolates from Russia.
Equations To Predict Antimicrobial MICs in Neisseria gonorrhoeae Using Molecular Antimicrobial Resistance Determinants.
The study identifies several genes and mutations associated with antimicrobial resistance in Neisseria gonorrhoeae, including PenA, mtrR, 23S rRNA, rpsJ, PorB, PonA, GyrA, ParC, and bla. These genetic elements contribute to resistance against various antibiotics such as ceftriaxone, cefixime, azithromycin, tetracycline, ciprofloxacin, and penicillin.
Antimicrobial Resistance Mechanisms, Multilocus Sequence Typing, and NG-STAR Sequence Types of Diverse Neisseria gonorrhoeae Isolates in KwaZulu-Natal, South Africa.
The study identified multiple AMR genes and mutations in Neisseria gonorrhoeae isolates from KwaZulu-Natal, South Africa, including blaTEM, penA_ins346D, ponA_L421P, mtrR_G45D, porB1b_G120K, porB1b_A121N, mtrR_disrupted, tetM, rpsJ_V57M, gyrA_S91F, gyrA_D95G, gyrA_D95A, parC_D86N, S87N, and S87I, which confer resistance to penicillin, tetracycline, and ciprofloxacin.
Antimicrobial Resistance Mechanisms, Multilocus Sequence Typing, and NG-STAR Sequence Types of Diverse Neisseria gonorrhoeae Isolates in KwaZulu-Natal, South Africa.
The study identified multiple AMR genes and mutations in Neisseria gonorrhoeae isolates from KwaZulu-Natal, South Africa, including blaTEM, penA_ins346D, ponA_L421P, mtrR_G45D, porB1b_G120K, porB1b_A121N, mtrR_disrupted, tetM, rpsJ_V57M, gyrA_S91F, gyrA_D95G, gyrA_D95A, parC_D86N, S87N, and S87I, which confer resistance to penicillin, tetracycline, and ciprofloxacin.
Antimicrobial Resistance Profiling and Phylogenetic Analysis of Neisseria gonorrhoeae Clinical Isolates From Kenya in a Resource-Limited Setting.
The study identified multiple AMR genes and mutations in Neisseria gonorrhoeae isolates from Kenya, including mutations in gyrA, parC, penA, ponA1, rpsJ, folP, mtrR, rpoB, pilQ, porB1b, and rplD, which confer resistance to fluoroquinolones, penicillins, cephalosporins, tetracyclines, sulfonamides, rifampicin, and macrolides.
The antimicrobial resistance landscape of Neisseria gonorrhoeae in New Zealand from November 2018 to March 2019 and the role of sexual orientation in transmission.
The study identified several AMR genes and mutations in Neisseria gonorrhoeae isolates from New Zealand, including blaTEM-1, blaTEM-135, tetM, 23S C2611T, rpsJ V57M, mtrR A39T, mtrR G45D, penA mutations, penB mutations, ponA L421P, gyrA mutations, parC mutations, and norM promoter mutations, which contribute to resistance against various antibiotics such as penicillin, tetracycline, azithromycin, ciprofloxacin, ceftriaxone, and cefixime.
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research